SOHM Launches SohMed(TM) Range of Branded OTC Medicines in U.S. Market
12 Novembro 2013 - 12:30PM
Marketwired
SOHM Launches SohMed(TM) Range of Branded OTC Medicines in U.S.
Market
SohMed(TM) Line of Branded Generic Products Caters to Growing
Population of OTC Medication Users
BUENA PARK, CA--(Marketwired - Nov 12, 2013) - SOHM, Inc.
(PINKSHEETS: SHMN), a manufacturer of generic pharmaceutical,
nutraceutical and cosmeceutical drug products, today announces the
U.S. launch of its umbrella brand, "SohMed™," positioning the
company with a firm position in the generic over-the-counter (OTC)
medicines segment for indications of pain, fever, cold, antacid and
alertness.
Shailesh Shah, president and CEO of SOHM, stated, "SOHM believes
in providing low-cost quality medicines to its customers. The
SohMed™ range of generic medicines will be made available in the
United States through a nationwide network of distributors,
warehouse stores, convenience stores and more. Additionally, we are
also in the active process of collaborating with large retail and
pharmacy chain stores to further extend our reach in the huge North
American market."
It is estimated that 35 percent of American adults use OTC
medication. Use of these medications is increasing and is expected
to continue to rise as more drugs move from prescription to OTC
status. Retail sales of OTC medicines in the U.S. totaled more than
$17 billion in 2010, unchanged from the preceding year, but showing
a more than $3 billion increase over a 10-year period, according to
the American College of Preventative Medicines. The global
market for OTC drugs is also on the rise, and is expected to
surpass $70 billion by 2015.
SOHM expects the growing market to strengthen demand for the
SohMed™ line of OTC products and create significant revenue growth
for the company.
"SOHM team is also working aggressively to supply these products
under white label agreement," concluded Shah. "With the launch of
SohMed™ range of products and some of the other products like
Salic-2® Gel, I-Prolec™ and Fohm® by Sohm®, we anticipate a big
jump in revenue during 2013 and beyond. During the first six months
of 2013, SOHM has already surpassed the revenue achieved in the
full 12 months of 2012. Our third-quarter product launches will
continue to drive company value and help SOHM achieve 100 percent
revenue growth in 2013."
ABOUT SOHM, Inc. SOHM, Inc. is a generic pharmaceutical
manufacturer that produces and markets generic drugs covering all
major treatment categories. Besides generic drugs, SOHM also has
manufacturing facilities for food supplements and cosmetics. The
Company has global headquarters located in California, U.S., with
manufacturing facilities in India. SOHM exports generic
pharmaceuticals worldwide, placing a heavy focus on distribution in
emerging markets in Africa, Latin America, and Southeast Asia. For
more information visit the company's website at: www.sohm.com
SAFE HARBOR STATEMENT This press release contains statements,
which may constitute "forward-looking statements" within the
meaning of the Securities Act of 1933 and the Securities Exchange
Act of 1934, as amended by the Private Securities Litigation Reform
Act of 1995. Those statements include statements regarding the
intent, belief or current expectations of SOHM, Inc., and members
of their management as well as the assumptions on which such
statements are based. Prospective investors are cautioned that any
such forward-looking statements are not guarantees of future
performance and involve risks and uncertainties, and that actual
results may differ materially from those contemplated by such
forward-looking statements. Important factors currently known to
management that could cause actual results to differ materially
from those in forward-statements include fluctuation of operating
results, the ability to compete successfully and the ability to
complete before-mentioned transactions. The company undertakes no
obligation to update or revise forward-looking statements to
reflect changed assumptions, the statements to reflect changed
assumptions, the occurrence of unanticipated events or changes to
future operating results.
For More Information Contact Investor Relations 714-522-6700
SOHM (PK) (USOTC:SHMN)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
SOHM (PK) (USOTC:SHMN)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024